Publication & Citation Trends
Publications
0 total
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Cited by 0
Semantic Scholar
CTNI-66. CERN 09-02: A PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT ADULT EPENDYMOMA
Cited by 0
Semantic Scholar
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma OA
Cited by 6
Semantic Scholar
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702 OA
Cited by 9
Semantic Scholar
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Cited by 14
Semantic Scholar
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM) OA
Cited by 1
Semantic Scholar
JS01.5.A PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT ADULT EPENDYMOMA. A CERN STUDY
Cited by 1
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(285)
Cancer Genomics and Diagnostics
(94)
Brain Metastases and Treatment
(58)
Radiomics and Machine Learning in Medical Imaging
(50)
Cancer, Hypoxia, and Metabolism
(48)
Affiliations
Northwestern University
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
James S. McDonnell Foundation
Western University